The assessment of Cyclophosphamide Chemotherapy Effect Loading-PLGA Nanoparticles Against Ovarian Cancer Cells Line (OVCAR-4 and PEO1). Journal of Pharmaceutical Negative Results. 2022;13(1):39-43. Accessed June 4, 2026. https://www.pnrjournal.com/index.php/home/article/view/180